Marksans Pharma Limited

NSE:MARKSANS.NS

305.7 (INR) • At close November 13, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q42013 Q32013 Q22013 Q12012 Q42012 Q32012 Q22012 Q1
Revenue 5,906.185,600.135,861.275,312.365,000.334,859.764,798.294,525.654,337.684,073.293,626.333,612.013,489.623,223.8943,583.633,564.693,311.523,304.7492,876.492,563.962,450.342,346.7232,483.652,690.412,352.531,993.942,184.342,738.092,210.561,847.4932,152.41,804.261,867.472,102.3122,174.072,555.32,101.591,705.2462,132.942,104.752,023.951,560.9041,687.7521,613.541,410.3111,239.0021,143.5351,055.264946.422
Cost of Revenue 3,627.083,706.262,728.192,527.192,427.62,438.412,394.832,232.122,148.212,428.121,675.271,753.811,622.971,738.9861,414.411,636.891,395.671,712.6981,401.431,326.481,242.751,422.5021,281.971,311.581,158.91,312.2591,144.531,761.821,263.251,318.8581,202.731,100.741,097.831,447.6841,110.851,363.091,175.3903.0851,174.031,182.61,194.661,013.923953.824922.467789.079696.359690.735599.413542.138
Gross Profit 2,279.11,893.873,133.082,785.172,572.732,421.352,403.462,293.532,189.471,645.171,951.061,858.21,866.651,484.9082,169.221,927.81,915.851,592.0511,475.061,237.481,207.59924.2211,201.681,378.831,193.63681.6811,039.81976.27947.31528.636949.67703.52769.64654.6281,063.221,192.21926.29802.161958.91922.15829.29546.981733.928691.073621.232542.643452.8455.851404.284
Gross Profit Ratio 0.3860.3380.5350.5240.5150.4980.5010.5070.5050.4040.5380.5140.5350.4610.6050.5410.5790.4820.5130.4830.4930.3940.4840.5120.5070.3420.4760.3570.4290.2860.4410.390.4120.3110.4890.4670.4410.470.450.4380.410.350.4350.4280.440.4380.3960.4320.427
Reseach & Development Expenses 0012500158.89000192.5739549128.6600083.1470000000000045.30900076.8100042.993128.9900197.56300045.377000
General & Administrative Expenses 000000000000000000000000000000000000047.73547.7350074.11800057.314000
Selling & Marketing Expenses 0000000000000000000000000000000000000234.318234.31800267.644000223.267000
SG&A 1,199.171,008932.6934.39682.38716.961,015.13894.14894.66824.26739.01614.3553.83452.14478.56438.78427.03563.134404.55406.32411.48496.228363.31428.54370.79438.332361.71359.9374.01428.709383.11352.21382.64357.262365.42365.27182.39133.699523.98187.09180.4590.032163.769185.341151.801511.733145.521135.0290
Other Expenses 0165.348189.96100.96110.09176.52141.53164.99-169.47120.5785.6758.8431.904-31.6836.681.82-1.5180.2678.8121.76-0.8861.57-7.9732.32787.893809.7800.1731.39714.81779.42697.81735.16757.709854.98733.22447.46458.055474.01452.2441.7374.45435.891426.268388.715171.556329.784275.745532.133
Operating Expenses 1,199.171,0082,022.891,821.191,689.671,465.31,764.441,631.381,572.011,196.031,458.621,331.091,167.99391.9141,344.621,286.161,288.15995.281,075.48951.57930.72777.573890.181,062.99898.41787.893809.7800.1731.39714.81779.42697.81735.16757.709854.98733.22447.46458.055474.01452.2441.7374.45435.891426.268388.715171.556329.784275.745532.133
Operating Income 1,079.93885.871,158.191,153.94883.061,066.14815.54803.68617.46422.82492.44527.11698.661,092.994824.6641.64627.7596.771399.58285.91276.87146.648311.5315.84295.22-106.211212.46145.74196.57-13.577152.07-4.921.714.337184.84430.34449.02363.074421.49422.08352.21169.675269.656224.864199.919371.086123.016180.106-127.849
Operating Income Ratio 0.1830.1580.1980.2170.1770.2190.170.1780.1420.1040.1360.1460.20.3390.230.180.190.1810.1390.1120.1130.0620.1250.1170.125-0.0530.0970.0530.089-0.0070.071-0.0030.0120.0020.0850.1680.2140.2130.1980.2010.1740.1090.160.1390.1420.30.1080.171-0.135
Total Other Income Expenses Net 120.25-436.7816.39-936.285.2-24.4153116.17146.99-567.44111.0670.6649.18166.271-48.4317.34-13.66-21.123-16.2350.7-0.7520.087-15.99-38.68.35-34.729-13.77-30.43-19.350-18.18-10.61-12.771,150.367-23.4-28.65-29.8101,279.02-47.87-35.381,018.35-28.381-39.941-32.598-4.817-35.998-34.129-35.943
Income Before Tax 1,200.181,002.751,126.581,137.68968.261,041.74792.02778.32764.45525.98603.5597.77747.84972.251776.39658.98614.04575.648383.35336.61276.12166.736295.51277.24303.57-56.779212.46145.74196.57-13.577152.06-4.921.714.337184.84430.34449.02363.074421.49422.08352.21169.675269.656224.864199.919366.26987.018145.977-163.792
Income Before Tax Ratio 0.2030.1790.1920.2140.1940.2140.1650.1720.1760.1290.1660.1650.2140.3020.2170.1850.1850.1740.1330.1310.1130.0710.1190.1030.129-0.0280.0970.0530.089-0.0070.071-0.0030.0120.0020.0850.1680.2140.2130.1980.2010.1740.1090.160.1390.1420.2960.0760.138-0.173
Income Tax Expense 309.51226.32296.93299.18263.88214.64168.96177.11162.61229.46120.78134.89121.84177.253186.99151.64120.37148.22187.7576.9151.368.21544.1771.5154.798.03137.9141.6452.3918.43923.4-9.69343.836-1.7173.29125.66103.539137.15105.4993.0360.31339.72819.5518.278-40.9774.9055.7286.973
Net Income 887.52782.89832.35835.18686.58819.32634.08612.53597.16296.52482.72462.88626794.998589.4507.34493.65427.427295.6259.7224.8298.521251.34196.2248.78-68.87167.6694.23136.38-32.182113.034.110.24-57.594179.34348.71314.69250.475277.17311.63254.69106.298224.841200.107187.831407.24682.113140.249-170.765
Net Income Ratio 0.150.140.1420.1570.1370.1690.1320.1350.1380.0730.1330.1280.1790.2470.1640.1420.1490.1290.1030.1010.0920.0420.1010.0730.106-0.0350.0770.0340.062-0.0170.0530.0020.005-0.0270.0820.1360.150.1470.130.1480.1260.0680.1330.1240.1330.3290.0720.133-0.18
EPS 1.961.731.841.841.521.971.571.521.460.721.21.111.531.921.421.211.21.020.710.630.520.230.60.480.58-0.170.410.230.33-0.0770.240.020.11-0.140.440.850.770.60.720.810.660.250.580.520.490.970.210.38-0.46
EPS Diluted 1.961.731.841.841.521.971.571.521.460.691.21.111.531.921.421.211.21.020.710.630.520.230.60.480.58-0.160.410.230.33-0.0770.240.020.11-0.140.440.850.770.60.720.810.660.250.580.520.490.970.210.36-0.44
EBITDA 1,433.851,261.711,378.221,329.451,120.621,205.58942.96944.2893.6789.84698.6686.65832.211,013.85878.91868.24702.01654.496473.11414.48345.96253.789363.44363.24354.862.642292.37245.92290.3877.46288.6164.782.5869.042235.73486.48524.07345.008524.61496.333427.97208.556355.12296.555264.57384.483145.728202.818-102.574
EBITDA Ratio 0.2430.1960.2350.250.2240.2480.1970.2090.2060.1860.1930.190.2380.30.2450.2440.2120.1980.1640.1620.1410.0920.1460.1350.1650.0010.1340.090.1310.0320.1340.0360.0440.0330.1410.2010.2490.2020.2460.2420.2110.1340.210.1840.1880.310.1670.218-0.108